Development of novel therapeutic agent for pachydermoperiostosis (PDP) using iPS cells derived from patients with PDP
Grant-in-Aid for Scientific Research (C)
Basic Section 53050:Dermatology-related
Kyoto University
Takashi Nomura
From 01 Apr. 2020, To 31 Mar. 2024, Project Closed
pachydermoperiostosis;prostaglandin;SLCO2A1;iPSC;肥厚性皮膚骨膜症;プロスタグランディン;iPS細胞;PGDH;遺伝子異常;人工多能性幹細胞;プロスタグランジン;リードスルー誘導薬